| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |